BullFrog AI Holdings, Inc. BFRG
AI Holdings, Inc. was incorporated in the State of Nevada in February 2020. BullFrog AI Holdings, Inc. is the parent company of BullFrog
AI, Inc. and BullFrog AI Management, LLC, which were incorporated in Delaware and Maryland, in 2017 and 2021, respectively. All our operations
are currently conducted through BullFrog AI Holdings, Inc. The Company's principal business address is 325 Ellington Blvd, Unit
of BullFrog AI, Inc.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $116.7K | — | $65.0K | $10.0K | — | — |
| Cost of revenue | $94.8K | — | $5.2K | $800 | — | — |
| Gross profit | $21.9K | — | $59.8K | $9.2K | — | — |
| R&D | $1.8M | $2.2M | $1.4M | $609.3K | $25.0K | — |
| SG&A | $4.8M | $5.0M | $4.0M | $1.9M | $327.3K | — |
| Total operating expenses | $6.6M | $7.2M | $5.4M | $2.5M | $555.4K | — |
| Operating income | -$6.6M | -$7.2M | -$5.4M | -$2.5M | -$555.4K | — |
| Interest expense | $5.6K | $18.2K | $79.1K | $347.1K | $40.4K | — |
| Net income | -$6.5M | -$7.0M | -$5.4M | -$2.8M | -$585.8K | — |
| EPS, basic | -0.63 | -0.85 | -0.89 | -0.70 | -14.00 | — |
| EPS, diluted | -0.63 | -0.85 | -0.89 | -0.70 | — | — |
| Shares, diluted (wtd. avg.) | 10.3M | 8.2M | 6.0M | 4.0M | 4.1M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $2.2M | $5.4M | $2.6M | $57.7K | $10.0K | $5.0K |
| Total current assets | $2.6M | $5.5M | $2.8M | $72.7K | $10.0K | — |
| Property, plant and equipment | $2.5K | $4.2K | $6.0K | $7.7K | — | — |
| Total assets | $2.8M | $5.6M | $2.8M | $80.4K | $10.0K | — |
| Accounts payable | $168.2K | $435.9K | $103.7K | $544.0K | $68.6K | — |
| Short-term debt | — | — | — | — | $34.0K | — |
| Total current liabilities | $672.0K | $588.1K | $184.3K | $3.1M | $1.0M | — |
| Total liabilities | $672.0K | $588.1K | $184.3K | $3.1M | $1.0M | — |
| Retained earnings | -$23.3M | -$16.8M | -$9.8M | -$4.4M | -$1.6M | — |
| Total equity | $2.1M | $5.0M | $2.6M | -$3.1M | -$1.0M | -$540.5K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$5.5M | -$5.6M | -$6.0M | -$910.9K | -$382.4K | — |
| Depreciation and amortisation | $1.7K | $1.7K | $1.7K | $1.0K | — | — |
| Stock-based compensation | $1.0M | $943.6K | $631.5K | $340.2K | $99.0K | — |
| Capital expenditure | — | — | — | $8.7K | — | — |
| Investing cash flow | — | — | — | -$8.7K | — | — |
| Financing cash flow | $2.4M | $8.4M | $8.6M | $967.3K | $387.4K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-011644.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $10.0K | $65.0K | — | $116.7K |
| Gross profit | — | — | $9.2K | $59.8K | — | $21.9K |
| Net income | — | -$585.8K | -$2.8M | -$5.4M | -$7.0M | -$6.5M |
Recent filings and events
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Director nominations Dates and mechanics for shareholders proposing directors. Item 5.08
- Other event Item 8.01
- Other event Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Other event Item 8.01
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Delisting notice Item 3.01
- Delisting notice Item 3.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2834
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.20T | 55.5x | 44.7% |
| JNJ | JOHNSON & JOHNSON | $635.76B | 23.9x | 6.0% |
| ABBV | AbbVie Inc. | $504.76B | 121.0x | 8.6% |
| MRK | Merck & Co., Inc. | $358.41B | 20.0x | 1.3% |
| ABT | ABBOTT LABORATORIES | $180.63B | 27.9x | 5.7% |
| PFE | PFIZER INC | $171.16B | 22.1x | -1.6% |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $132.80B | 34.2x | 8.9% |
| BMY | BRISTOL MYERS SQUIBB CO | $125.59B | 17.8x | -0.2% |